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Abstract
Exercise and physical therapies are increasingly being considered as a lifestyle intervention in people with Huntington’s disease (HD). 
In addition to possible effects on motor function, there may be benefits in mood, behaviour and cognition from early in the disease. Certainly 
exercise may also infer general health benefits and there are recent suggestions that exercise may indeed potentiate disease modification. 
This review provides an overview of a strategic approach to the development and evaluation of complex exercise interventions in this 
neurodegenerative disease with a view to informing future clinical trials.
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Huntington’s disease (HD) is a genetic disease with autosomal dominant 
transmission and is unique amongst neurodegenerative diseases in that 
predictive testing is available before clinical symptoms are evident.1 As 
such, individuals with a family history of HD can choose to be tested 
and can establish if they will eventually get the disease. Some individuals 
choose not to know whether they carry the gene for HD, or are too young 
to be tested and are therefore considered at risk. For both the premanifest 
(those with a positive gene test but not showing symptoms) and at risk 
groups (those who have not taken the genetic test), there is the potential 
to develop interventions that can change the course or delay the onset of 
the disease. There is some evidence to suggest that lifestyle factors, such 
as activity level and education, may impact age of onset.2,3 Many factors 
can influence age of onset and extensive research is being conducted into 
identifying biomarkers. In people who are at risk or who are premanifest, 
the potential for lifestyle management and exercise as an intervention 
is intriguing. 
Even before the onset of clinical symptoms, in the so-called 
prodromal phase, there is a slowly progressive loss of brain volume 
and degeneration of the basal ganglia.4 Despite relatively widespread 
degeneration, clinical symptoms may not be evident for up to 10 years 
from the start of these neural changes. At this stage and in early onset 
HD, the development of compensatory networks may account for the 
lack of overt clinical signs, as new connections are developed to take 
over from damaged ones. These networks have the potential to be 
facilitated by experience and environment.  Furthermore, it has been 
suggested that motor training may be one approach that can help to 
drive compensatory neural networks,5 thus compensating for the failing 
brain. In addition to possible effects on motor function, these therapies 
also have the potential to affect mood, behaviour and cognition from 
early in the disease.6,7
 
Over the past 6 years, the Cardiff Physiotherapy Group has taken a staged 
approach utilising the Medical Research Council Framework8, to develop 
exercise and physical interventions for people with HD. Our group has 
consulted with users, lay bodies and healthcare professionals to develop 
structured exercise interventions and identify barriers and facilitators 
to exercise in this population.9 We conducted the first randomised, 
controlled feasibility study of a defined, short-term, home-based exercise 
intervention in people with HD10 and have recently completed a mixed 
methodology, randomised feasibility study and process evaluation of a 
supported community-based gym exercise and walking programme.11 
Additional controlled feasibility studies are currently underway or in 
set up, each with the aim of further advancing our understanding of 
different modes of exercise. Here, we describe our work to date and put 
forth suggestions for critical features of exercise studies based on our 
experiences in designing and delivering interventions in this population.
Design and Delivery of Exercise-based  
Interventions in Huntington’s Disease –  
Cardiff Experiences
Home-based Programmes
Move to Exercise was a pilot study designed to evaluate a purpose-
developed home exercise DVD in people with HD.12 In this study, 25 
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subjects with early to mid-stage Huntington’s disease were randomly 
allocated to either an exercise intervention (n=13) or a control group 
(n=12). Subjects in the exercise intervention group were asked to 
perform exercises at home three times a week for 8 weeks using an 
exercise DVD. The control group received their usual care. Adherence 
in the intervention group was calculated from exercise diaries and 
measures of gait, balance, function, level of physical activity and 
quality of life were evaluated. Eleven participants from the intervention 
and 10 from the control group completed the study. Mean adherence 
was 29.4 ± 1.8 for the 32 prescribed sessions. There were no related 
adverse events. Analysis of covariance revealed differences between 
groups in gait speed, balance, function and level of physical activity, 
but not quality of life as measured by the SF-36. Effect sizes were 
large (>0.8) for the majority of the outcomes. 
One important finding to emerge from the Move to Exercise study 
was that while the programme resulted in positive outcomes in 
the intervention group, a key factor to participant’s successfully 
completing the exercise was caregiver support.10 Provision of 
appropriate support can be crucial in maintaining adherence and 
this seems to be particularly true for people with neurodegenerative 
diseases.13 In the Move to Exercise study, this support took many 
forms, including encouragement, support and occasionally physical 
assistance to perform the exercises. Further work is now required to 
understand in depth how to best support people with HD to exercise, 
given their range of cognitive and behavioural impairments.
Another important factor that could have affected the outcomes in Move 
to Exercise was whether the benefits seen could have been simply the 
result of social contact, or whether there was a specific training effect. 
A brief review of exercise studies conducted in people with Parkinson’s 
disease (PD) and Alzheimer’s disease (AD) has highlighted this issue. 
Of 69 studies in PD (n=51) and dementia (n=18), only 39 included a 
comparator arm. Main controls were physical (n=32) and social contact 
(n=7). The potential beneficial effect of social contact cannot be 
overlooked in exercise or physiotherapy interventions in people with 
neurodegenerative disease, particularly when the outcomes are related 
to quality of life or cognition. While it is important to first establish proof 
of principle, it is crucial for more studies to include comparator arms to 
properly tease out any intervention effects.
One potential issue with a DVD-based exercise programme, such 
as Move to Exercise, is that it is not individualised or context 
specific to the person’s home environment (an aspect known to 
be required to ensure consistent learning and carry-over of new 
motor skill).14 It may be that some people with HD (particularly in 
the mid-stages) would benefit more from intensive, one-to-one 
therapy, where adherence and safety can be assured and in addition 
individual progression specific to a person’s particular clinical and 
social needs can be accommodated. 
In order to address these issues, we designed a home-based, 1:1 
intervention [TRAIN-HD; ISRCTN 94284668]. This ongoing study aims 
to examine the feasibility and potential benefit of a home-based, 
task-specific physiotherapy led exercise programme on mobility, 
physical functioning, health-related quality of life and individualised 
goals determined in collaboration with the client and therapist. The 
programme was designed to address some of the common areas of 
difficulties seen in individuals with HD, namely walking, sit to stand 
and upright balance control. 
Delivering interventions in a person’s home has two important 
benefits. First, it is likely to improve recruitment and adherence to 
the programme by eliminating the need for participants to travel 
to a centre for service delivery. Second, physiotherapy provided in 
the home setting is by nature context-specific and is likely to be 
more relevant and meaningful to the participant to promote more 
effective outcomes with improved goal setting.15,16 Although such 
an approach requires increased travel time for the therapist and 
possibly increased isolation for both the therapists and people 
with HD, providing therapy at home puts fewer burdens on the 
patient and their family.17
 
The benefits of a programme based on task-specific practice as a 
means to improve functional abilities and task performance have 
been documented in individuals with neurological conditions such as 
stroke and PD.18,19 Task-specific practice involves practice of a task – 
such as walking, rising from a chair, or reaching – using repetitions, 
alterations of the environment and modification of the conditions 
of the task as a means of progressing task difficulty.20 In addition to 
functional improvements, task-specific practice has been associated 
with neuroplastic changes within the cortical and sub-cortical areas of 
the brain,21,22 indicating learning has occurred. 
Gym-based Programmes
While home-based programmes have many possible benefits, including 
eliminating need for participant travel, convenience for participants and 
caregivers, and flexibility as to when the exercise is performed, such 
programmes also have inherent limitations. The range of equipment 
available in the home is limited, and thus participants may lose interest 
in a programme more readily. Furthermore, it is difficult to confirm 
fidelity of intervention if it is not directly supervised and monitored with 
appropriate equipment. Finally, exercising in an environment outside 
the home, such as a gym-based setting, may be more appealing 
for some participants, secondary to the natural social interaction 
that happens. 
In order to determine if a gym-based programme was indeed feasible 
for people with HD, we designed a mixed-mode exercise programme 
for people with early-mid stage HD.11 This multi-centre controlled study 
(ISRCTN 59910670) evaluated a 12-week exercise programme that 
included a 1x/week supervised gym session of stationary cycling and 
resistance exercises and 2x/week independent home-based walking 
programme. Thirty-one participants (16 male) [mean (SD) age 50.4 (11.4) 
years] with mid stage HD were randomly allocated to intervention 
(n=16) or control (usual care) (n=15). Acceptability was determined from 
subjective reports of tolerability and physiological measures recorded 
during the gym sessions. Assessment of benefit (blinded) included 
measures of physical abilities, disease severity and quality of life 
(SF-36). The retention rate was 81  % (nine of the 11 individuals who 
started the intervention completed it) and seven out of those nine 
attended more than 75  % (9/12) of the gym sessions. There were no 
related adverse events and the intervention was well tolerated by most 
participants. The confidence interval for the effect observed for the 
mental component summary (MCS) score of the SF-36 between groups 
([n=9; intervention, n=13; control; effect estimate: 7, 95 % CI [0.4, 13.7]) 
suggests clinical benefit of the intervention. Moderate effect sizes for 
cognitive outcomes and measures of walking were also observed. 
Information obtained from process interviews conducted as part of this 
study did indeed suggest that some of the participants were very happy 
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to go to the gyms and enjoyed the social interaction the gym setting 
provided.23 However, some participants found it to be a threatening 
environment and had concerns about how they were perceived in 
public. In addition, significant numbers of individuals approached for 
this study during recruitment chose not to enrol when they were told 
the exercise was taking place in a gym. We therefore propose that in 
order to develop a successful exercise intervention that is acceptable 
to a wide number of people with HD, it is important to include personal 
preferences in terms of exercise environment to facilitate participant 
uptake and adherence. 
To this end, our group has now developed a protocol that is designed 
to test the feasibility and potential benefit of an aerobic exercise 
programme in people with very early stage HD.  Similar work has 
been conducted in patients with mild cognitive impairment24 with 
promising results. Our proposed study (EXeRT) will incorporate the 
personal preferences of the participant in terms of location and 
mode of exercise, and individualised goal setting will be central to the 
programme. This trial has two arms: a) 12-week exercise training with 
aerobic and anaerobic training components (intervention group), and 
b) a control group asked to continue as normal.
The intervention group will complete a 45-minute structured exercise 
intervention three times per week and the intervention will take place 
either in a community-based gym, or in cases where access to a gym 
is restricted or is not the personal preference of the participant, the 
intervention will take place in the participant’s home with exercise 
equipment provided. Regardless of whether exercise is undertaken in 
a gym or at the home, the session will follow a set programme that 
will include a 10-minute warm up and stretches, followed by up to 
30 minutes of exercise (treadmill, elliptical trainer or stationary bike) 
within an aerobic zone. Considering the suggestion that people with 
HD may have a lower anaerobic threshold than healthy individuals,25 and 
furthermore the sedentary nature of people with HD, we will initially 
train individuals at the lower end of the 75–85  % of heart rate (HR) 
reserve range (peak HR minus resting HR, where peak HR is determined 
by the incremental bike test). Rating of perceived exertion (RPE, CR10 
scale) and HR will be monitored. 
This study will incorporate increased exposure in accordance with 
frequency and intensity exercise prescription protocols, which 
extends upon our previous work in COMMET-HD.11 Our proposed 
intervention will be more frequent than previous interventions and will 
be closely monitored by trained therapists to ensure a specific training 
effect from exercise. 
Critical Features of Exercise Study Designs – 
Lessons Learned
While research in the area of exercise and physical activity in HD is in 
its infancy, pilot and feasibility data from our recent studies has already 
yielded important knowledge, which can be translated and applied to 
future research. Here we provide a summary of the key study design 
considerations for exercise and physical activity studies in people with HD. 
Adherence
Documenting adherence and understanding barriers and facilitators to 
adherence to exercise programmes is essential to effective translation of 
clinical research. In our studies to date, adherence has been the primary 
measure; if individuals do not or will not adhere to a programme, its utility 
in the real world is limited. Accurate adherence data is best obtained 
by direct observation and one-to-one sessions, such as those provided 
in our studies to date (allow for use of session logs documented by 
research staff). For home programmes, exercise diaries are often used. 
Utility of exercise diaries do depend, however, on participant self-report. 
They must therefore be easy to use and should ideally be reviewed at 
least weekly with the research staff. Reasons for missed sessions should 
also be documented. 
Outcome Measures
There have been considerable efforts over the past 10 years to 
determine the best outcome measures for use in clinical trials 
in the HD population. Clinical rating scales such as the Unified 
Huntington’s Disease Rating Scale (UHDRS) are subject to variability, 
however, and may not be sufficiently sensitive to detect changes 
in response to an exercise intervention. While traditional measures 
of health and fitness have potential, it is very important to develop 
an understanding of exercise-related mechanistic effects. Our 
experiences suggest that measures of health and fitness are 
important for establishing intervention fidelity and are best used 
in supporting measures of exercise adherence. Establishing 
whether it is possible to delay the onset or progression of disease 
by preventing structural or cellular changes that are inherent in 
the development of symptoms is a crucial target. Studies such 
as TRACK-HD,4 which aim to identify sensitive and specific markers 
of disease progression and specific in-depth studies of the effect of 
exercise on brain function in HD are extremely relevant and important 
in the ongoing development and conduct of exercise trials in HD. 
Use of Mixed Methodology
Exercise is a complex intervention where the activity itself and the 
local, social and environmental contexts interact to produce the 
outcome that is measured.8 Mixed methods designs that incorporate 
both quantitative and qualitative methodologies, for example process 
interviews of the participants, as well as the assessors and intervention 
therapists are therefore extremely important in promoting an in-depth 
understanding and appropriate interpretation of the findings. Practical 
considerations about the trial design, as well as acceptability of the 
assessment and intervention procedures, are further relevant to 
support design on Phase III trials. 
Goal Setting
While HD is a degenerative, neurological condition, the importance of 
setting goals that result in positive changes in participation, lifestyle 
or daily living scales cannot be overstated. Use of tools such as Goal 
Attainment Scaling (GAS)27 can help patients to identify a specific focus 
and purpose of an exercise routine. We have successfully utilised the 
GAS in TRAIN-HD, as a means to develop and evaluate a collaborative 
training programme. While GAS should not be utilised alone as a primary 
outcome measure, it can be a sensitive measure of change in complex 
interventions such as TRAIN, where the focus of the intervention is 
functional and task-specific training.28 As Turner-Stokes points out, GAS 
provides a person-centred perspective and can support interpretation 
of results from standardised outcome measures. 
Choice of Exercise
Based on our extensive consultations with people with HD and our prior 
research in this area, we know that patients with HD need flexibility in 
terms of access to exercise facilities. For people with HD, behavioural 
and cognitive impairments, such as apathy, and difficulty in planning, 
organising, sequencing and prioritising their daily activities, can 
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significantly impact on their ability to initiate and adhere to an exercise 
programme.29,30 Consideration of these disease-specific factors, as well 
as understanding personal preferences and how they may change with 
the presence of a disease or disability,31 is necessary to successful 
implementation of any exercise-based programme. We therefore 
suggest that future studies incorporate a structured, mixed delivery 
approach that can be modified according to personal needs to facilitate 
people with HD to engage in exercise. Even though there will be some 
differences in intensities or specificity of training, the important factor 
is that an increase in overall physical activity is achieved. 
Structure and Support to Help  
People with Engagement
Due to the nature of this disease and the complex interaction of both 
motor and behavioural symptoms in people with HD, we believe that a 
high level of structure and support is crucial for the successful uptake of 
exercise and physical activity intervention. Furthermore, this structure is 
important to facilitate the potential for those receiving the intervention to 
develop the skills to participate independently in an exercise programme 
on completion of a particular study. Indeed the promotion of self-efficacy 
and self-determined lifestyle changes in relation to physical activity are 
essential in supporting sustained exercise habits.32
Optimal Dose Response
To date, there is insufficient research available in the field to support 
suggestions of what the appropriate exercise dose may be. Our recent study 
in people with early to mid-stage people attending 1x/week gym session and 
2x/week at home walking programme showed potential for benefit in 
cognition and walking endurance, with moderate effect sizes identified. 
It is therefore likely that a higher dose, or intensity, is required to 
effectuate change. This recommendation needs to be considered 
with caution, particularly as fatigue may be an issue for some people 
with HD. Qualitative reports obtained during our studies highlighted 
that some people with HD did report fatigue following the exercise 
intervention; these individuals required some individual modification 
of their programme to help them to manage their fatigue. Fatigue 
has not, as yet, been considered a primary symptom of HD and we 
argue that it is important to know how prevalent a feature fatigue 
in HD may be. The underlying aetiology of fatigue and whether it is 
secondary to excessive movements, or part of the HD phenotype 
as is accepted in multiple sclerosis,33 has yet to be determined. 
To this end, in future work we plan to measure fatigue specifically, 
both as an outcome measure and as a potential adverse effect of the 
exercise intervention.
Forward-thinking – The Future of Physical 
Therapies in Huntington’s Disease
It is clear that the changing clinical needs of the person with HD require 
stratified treatment approaches; the ultimate goal for our group is to 
provide a range of evidenced-based intervention strategies for people 
at varying stages of HD, based on their specific clinical presentations. 
Here we present some of the lessons that we have learned along 
the way that we believe are critical to the design of future trials. We 
further recognise the importance of mechanistic evaluation in future 
exercise studies. Contemporary brain imaging techniques including 
structural and functional magnetic resonance imaging as well as 
diffusion tensor imaging will be important in future studies.34–37
Before Phase III trials are implemented, we believe that exercise 
interventions need to be appropriately described for implementation 
and replication. Furthermore, there should be a systematic published 
body of literature in support of the intervention which provides not 
only indications of acceptability but also of potential benefit and 
cost savings. Considering the potential that exercise has both in 
terms of general health benefit and in disease modification, these 
interventions can clearly provide important quality of life benefits 
to people with this devastating disease, as well as a platform 
for future clinical trials, where exercise and physical activity are 
complementary to pharmacological and surgical interventions with 
the ultimate aim of disease modification. n
